Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 523979, 8 pages
http://dx.doi.org/10.1155/2014/523979
Review Article

The MicroRNAs as Prognostic Biomarkers for Survival in Esophageal Cancer: A Meta-Analysis

1Medical College of Shihezi University, Shihezi, Xinjiang 832000, China
2Department of Thoracic and Cardiovascular Surgery, Hospital of Xinjiang Production and Construction Corps, Urumchi, Xinjiang 830002, China
3Department of Pathology, Medical College of Shihezi University, Shihezi, Xinjiang 832000, China
4Department of Thoracic and Cardiovascular Surgery, First Hospital Affiliated to Medical College of Shihezi University, Shihezi, Xinjiang 832000, China

Received 14 March 2014; Revised 24 May 2014; Accepted 18 June 2014; Published 6 July 2014

Academic Editor: Manuela Ferracin

Copyright © 2014 Wenbo Fu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Lagergren, R. Bergström, A. Lindgren, and O. Nyrén, “Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma,” The New England Journal of Medicine, vol. 340, no. 11, pp. 825–831, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. P. C. Enzinger and R. J. Mayer, “Esophageal Cancer,” The New England Journal of Medicine, vol. 349, no. 23, pp. 2241–2252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Sant, T. Aareleid, F. Berrino et al., “EUROCARE-3: Survival of cancer patients diagnosed 1990–94—results and commentary,” Annals of Oncology, vol. 14, supplement 5, pp. v61–v118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. McCann, “Esophageal cancers: changing character, increasing incidence.,” Journal of the National Cancer Institute, vol. 91, no. 6, pp. 497–498, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. M. B. Orringer, “Multimodality therapy for esophageal carcinoma—update,” Chest, vol. 103, no. 4, pp. 406S–409S, 1993. View at Google Scholar · View at Scopus
  7. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. S. Mattick and I. V. Makunin, “Small regulatory RNAs in mammals,” Human Molecular Genetics, vol. 14, no. 1, pp. R121–R132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. V. N. Kim, “MicroRNA biogenesis: coordinated cropping and dicing,” Nature Reviews Molecular Cell Biology, vol. 6, no. 5, pp. 376–385, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Hutvágner and P. D. Zamore, “A microRNA in a multiple-turnover RNAi enzyme complex,” Science, vol. 297, no. 5589, pp. 2056–2060, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Winter, S. Jung, S. Keller, R. I. Gregory, and S. Diederichs, “Many roads to maturity: microRNA biogenesis pathways and their regulation,” Nature Cell Biology, vol. 11, no. 3, pp. 228–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Calin, C. Sevignani, C. D. Dumitru et al., “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999–3004, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Schetter, S. Y. Leung, J. J. Sohn et al., “MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma,” Journal of the American Medical Association, vol. 299, no. 4, pp. 425–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Yanaihara, N. Caplen, E. Bowman et al., “Unique microRNA molecular profiles in lung cancer diagnosis and prognosis,” Cancer Cell, vol. 9, no. 3, pp. 189–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. V. Iorio, M. Ferracin, C.-G. Liu et al., “MicroRNA gene expression deregulation in human breast cancer,” Cancer Research, vol. 65, no. 16, pp. 7065–7070, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. V. Iorio, R. Visone, G. Di Leva et al., “MicroRNA signatures in human ovarian cancer,” Cancer Research, vol. 67, no. 18, pp. 8699–8707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Zhao, A. J. Schetter, G. B. Yang et al., “MicroRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma,” International Journal of Cancer, vol. 132, no. 12, pp. 2901–2909, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Zhang, Q. Wang, D. Zhao et al., “The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma,” Clinical Science, vol. 121, no. 10, pp. 437–447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” British Medical Journal, vol. 339, article b2535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Zhang, S. Riethdorf, G. Wu et al., “Meta-analysis of the prognostic value of circulating tumor cells in breast cancer,” Clinical Cancer Research, vol. 18, no. 20, pp. 5701–5710, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, “Practical methods for incorporating summary time-to-event data into meta-analysis,” Trials, vol. 8, article 16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Google Scholar · View at Scopus
  24. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. B. E. G. Rothberg, M. B. Bracken, and D. L. Rimm, “Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis,” Journal of the National Cancer Institute, vol. 101, no. 7, pp. 452–474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. G. Koerkamp, N. N. Rahbari, M. W. Büchler, M. Koch, and J. Weitz, “Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis,” Annals of Surgical Oncology, vol. 20, no. 7, pp. 2156–2165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Lin, L. Pan, S. Guo et al., “Prognostic role of microRNA-181a/b in hematological malignancies: a meta-analysis,” PLoS ONE, vol. 8, no. 3, Article ID e59532, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Hummel, D. J. Hussey, M. Z. Michael et al., “MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma,” Annals of Surgical Oncology, vol. 18, no. 1, pp. 253–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Hong, Y. Han, H. Zhang et al., “The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma,” Annals of Surgery, vol. 251, no. 6, pp. 1056–1063, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Tanaka, H. Miyata, M. Yamasaki et al., “Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer,” Annals of Surgical Oncology, vol. 20, supplement 3, pp. 607–615, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Komatsu, D. Ichikawa, H. Takeshita et al., “Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma,” Expert Opinion on Biological Therapy, vol. 12, supplement 1, pp. S53–S59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Wang, C. Zhang, J. He et al., “MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma,” Digestive Diseases and Sciences, vol. 58, no. 7, pp. 1863–1870, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Hamano, H. Miyata, M. Yamasaki et al., “Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway,” Clinical Cancer Research, vol. 17, no. 9, pp. 3029–3038, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. W.-J. Ma, G.-D. Lv, A. Tuersun et al., “Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma,” Molecular Biology Reports, vol. 38, no. 5, pp. 3253–3260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Li, W. M. Mao, Z. G. Zheng, Z. M. Dong, and Z.Q. Ling, “Down-regulation of pten expression modulated by dysregulated mir-21 contributes to the progression of esophageal cancer,” Digestive Diseases and Sciences, vol. 58, pp. 3483–3493, 2013. View at Google Scholar
  37. X. Li, R. Lin, and J. Li, “Epigenetic silencing of MicroRNA-375 regulates PDK1 expression in esophageal cancer,” Digestive Diseases and Sciences, vol. 56, no. 10, pp. 2849–2856, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. K. L. Kong, D. L. W. Kwong, T. H. Chan et al., “MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor,” Gut, vol. 61, no. 1, pp. 33–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. E. A. Mathé, H. N. Giang, E. D. Bowman et al., “MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival,” Clinical Cancer Research, vol. 15, no. 19, pp. 6192–6200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Ogawa, H. Ishiguro, Y. Kuwabara et al., “Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR,” Medical Molecular Morphology, vol. 42, no. 2, pp. 102–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kano, N. Seki, N. Kikkawa et al., “MiR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma,” International Journal of Cancer, vol. 127, no. 12, pp. 2804–2814, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. B. L. Wu, L. Y. Xu, Z. P. Du et al., “MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145,” World Journal of Gastroenterology, vol. 17, no. 1, pp. 79–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Ko, G. Zehong, C. Virtanen et al., “MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy,” Annals of Thoracic Surgery, vol. 94, no. 4, pp. 1094–1103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Feber, L. Xi, A. Pennathur et al., “MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma,” Annals of Thoracic Surgery, vol. 91, no. 5, pp. 1523–1530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. L. X. Yan, X. F. Huang, Q. Shao et al., “MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis,” RNA, vol. 14, no. 11, pp. 2348–2360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Dillhoff, J. Liu, W. Frankel, C. Croce, and M. Bloomston, “MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival,” Journal of Gastrointestinal Surgery, vol. 12, no. 12, pp. 2171–2176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Rossi, M. Shimizu, E. Barbarotto et al., “MicroRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival,” Blood, vol. 116, no. 6, pp. 945–952, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Wu, M. Li, C. Hu, and H. Duan, “Clinical significance of serum mir-223, mir-25 and mir-375 in patients with esophageal squamous cell carcinoma,” Molecular Biology Reports, vol. 41, no. 3, pp. 1257–1266, 2014. View at Google Scholar